miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression

Venhar Gurbuz1, Sinan Sozen2, Cenk Y Bilen3

  • 1Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06510, Turkey.

Oncology Letters
|October 11, 2021
PubMed

Insights

This study reveals key epigenetic regulators in prostate cancer (PCa), identifying specific microRNAs (miRs) and their target genes like DNA methyltransferases (DNMTs) and PTEN. Findings highlight their association with cancer aggressiveness and potential as therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • MicroRNAs (miRs) are crucial regulators of gene expression at the transcriptome level.
  • Epigenetic modifications, including DNA methylation, play a significant role in cancer development and progression.
  • Understanding the interplay between epigenetic factors and miRs is vital for advancing prostate cancer (PCa) research.

Purpose of the Study:

  • To investigate the epigenetic-based miRNA-mRNA regulatory network involving specific miRs (miR-34b, miR-34c, miR-148a, miR-152, miR-200a, miR-200b) and their target genes in PCa.
  • To analyze the expression levels of target genes, including DNA methyltransferases (DNMT1, DNMT3a, DNMT3b), PTEN, and NKX3.1, in PCa and metastatic PCa (Met-PCa) compared to controls.
  • To elucidate the associations between these epi-miRNAs, their target genes, and PCa aggressiveness, including PSA levels, Gleason Score (GS), and TNM staging.

Main Methods:

  • Quantitative reverse transcription PCR (RT-qPCR) was employed to measure the expression levels of selected miRs and target genes.
  • Statistical analyses were performed to identify significant associations and correlations between gene expression, PCa status, and clinical parameters.
  • The study focused on analyzing the 'epi-miRNA-mRNA' regulatory network and potential feedback loops.

Main Results:

  • NKX3.1 expression showed no significant difference across groups.
  • DNMT1 was upregulated in PCa and Met-PCa, while DNMT3a, DNMT3b, and PTEN were downregulated.
  • Overexpression of DNMT1 correlated with decreased PTEN expression and was associated with PCa aggressiveness (PSA, GS, TNM staging).
  • Specific miRs (e.g., miR-148a, miR-152, miR-200b) were significantly associated with target genes, with some miRs shown to increase DNMT1 and suppress PTEN.
  • A significant negative association between PTEN and DNMT1 was observed in Met-PCa.

Conclusions:

  • The study identified a complex 'epi-miRNA-mRNA' regulatory network in PCa, involving key genes like DNMT1 and PTEN.
  • Aberrant expression of these epi-miRNAs and their target genes contributes to PCa progression and aggressiveness.
  • The findings highlight the potential of targeting these epigenetic mechanisms and miRs for novel anti-cancer therapeutics in PCa.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K